Basic and clinical studies on functional RNA molecules for advanced medical technologies

Journal of Nippon Medical School

Volumn 77, Issue 2, 2010, Pages 71-79

  Takizawa, Toshihiro ^a   Gemma, Akihiko ^a   Ui Tei, Kumiko ^b   Aizawa, Yasunori ^c   Sadovsky, Yoel ^d   Robinson, John M ^e   Seike, Masahiro ^a   Miyake, Koichi ^a,f  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f KYOTO UNIVERSITY   (Japan)

Author keywords

Lung cancer; MicroRNA; Noncoding RNA; Placenta; Small interfering RNA

Indexed keywords

MICRORNA; SMALL INTERFERING RNA; UNTRANSLATED RNA;

GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TECHNOLOGY; GENE THERAPY; HUMAN; MEDICAL TECHNOLOGY; NONHUMAN; REVIEW; RNA ANALYSIS; RNA INTERFERENCE;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENE THERAPY; GENETIC TECHNIQUES; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; MICRORNAS; PLACENTA; PREGNANCY; PREGNANCY PROTEINS; PROTEOMICS; RNA; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA, UNTRANSLATED;

EID: 77950922176     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.77.71     Document Type: Review

References (55)

1. Zaratiegui M, Irvine DV, Martienssen RA: Noncoding RNAs and gene silencing. Cell 2007; 128: 763-776.
2. Filipowicz W, Jaskiewicz L, Kolb FA, Pillai RS: Posttranscriptional gene silencing by siRNAs and miRNAs. Curr Opin Struct Biol 2005; 15: 331-341. (Pubitemid 40826453)
3. Liu J, Carmell MA, Rivas FV, et al.: Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004; 305: 1437-1441. (Pubitemid 39167657)
4. Ui-Tei K, Naito Y, Takahashi F, et al.: Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res 2004; 32: 936-948. Print 2004. (Pubitemid 38854696)
5. Naito Y, Yamada T, Ui-Tei K, Morishita S, Saigo K: siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. Nucleic Acids Res 2004; 32: W124-129. (Pubitemid 38854696)
6. Jackson AL, Bartz SR, Schelter J, et al.: Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 2003; 21: 635-637. (Pubitemid 36638089)
7. Lim LP, Lau NC, Garrett-Engele P, et al.: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-773. (Pubitemid 40292988)
8. Yuan YR, Pei Y, Ma JB, et al.: Crystal structure of A. aeolicus argonaute, a site-specific DNA-guided endoribonuclease, provides insights into RISC-mediated mRNA cleavage. Mol Cell 2005; 19: 405-419. (Pubitemid 41078780)
9. Ui-Tei K, Naito Y, Nishi K, Juni A, Saigo K: Thermodynamic stability and Watson-Crick base pairing in the seed duplex are major determinants of the efficiency of the siRNA-based off-target effect Nucleic Acids Res 2008; 36: 7100-7109.
10. Naito Y, Yoshimura J, Morishita S, Ui-Tei K: siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect. BMC Bioinformatics 2009; 10: 392.
11. Dykxhoorn DM, Novina CD, Sharp PA: Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 2003; 4: 457-467.
12. Brummelkamp TR, Bernards R, Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553. (Pubitemid 34408678)
13. Wiznerowicz M, Trono D: Conditional suppression of cellular genes: lentivirus vector-mediated druginducible RNA interference. J Virol 2003; 77: 8957-8961. (Pubitemid 36936105)
14. Miyake K, Flygare J, Kiefer T, et al.: Development of cellular models for ribosomal protein S19 (RPS19)-deficient diamond-blackfan anemia using inducible expression of siRNA against RPS19. Mol Ther 2005; 11: 627-637. (Pubitemid 40353120)
15. Flygare J, Kiefer T, Miyake K, et al.: Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia. Blood 2005; 105: 4627-4634.
16. Miyake K, Utsugisawa T, Flygare J, et al.: Ribosomal protein S19 deficiency leads to reduced proliferation and increased apoptosis but does not affect terminal erythroid differentiation in a cell line model of Diamond-Blackfan anemia. Stem Cells 2008; 26: 323-329.
17. Tomar RS, Matta H, Chaudhary PM: Use of adeno-associated viral vector for delivery of small interfering RNA. Oncogene 2003; 22: 5712-5715.
18. Wang X, Skelley L, Cade R, Sun Z: AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage. Gene Ther 2006; 13: 1097-1103.
19. Zincarelli C, Soltys S, Rengo G, Rabinowitz JE: Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther 2008; 16: 1073-1080.
20. Igarashi T, Miyake K, Masuda I, Takahashi H, Shimada T: Adeno-associated Vector (Type 8)-mediated Expression of sflt-1 Efficiently Inhibits Neovascularization in A Murine Choroidal Neovascularization Model. Hum Gene Ther 2010; in press.
21. Huber LA: Is proteomics heading in the wrong direction? Nat Rev Mol Cell Biol 2003; 4: 74-80.
22. Rice GE, Georgiou HM, Ahmed N, Shi G, Kruppa G: Translational proteomics: developing a predictive capacity - a review. Placenta 2006; 27 Suppl A: S76-86.
23. Corthals GL, Wasinger VC, Hochstrasser DF, Sanchez JC: The dynamic range of protein expression: a challenge for proteomic research. Electrophoresis 2000; 21: 1104-1115.
24. Durr E, Yu J, Krasinska KM, et al.: Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol 2004; 22: 985-992. (Pubitemid 39014475)
25. Robinson JM, Ackerman WE 4th, Tewari AK, Kniss DA, Vandre DD: Isolation of highly enriched apical plasma membranes of the placental syncytiotrophoblast. Anal Biochem 2009; 387: 87-94.
26. Liu J, Aoki M, Ilia I, et al.: Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998; 20: 31-36. (Pubitemid 28410339)
27. Bashir R, Britton S, Strachan T, et al.: A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 1998; 20: 37-42. (Pubitemid 28410340)
28. Bansal D, Miyake K, Vogel SS, et al.: Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003; 423: 168-172. (Pubitemid 36569539)
29. Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown RH Jr: Dysferlin interacts with annexins Al and A2 and mediates sarcolemmal wound-healing. J Biol Chem 2003; 278: 50466-50473. (Pubitemid 37548892)
30. Vandre DD, Ackerman WE 4th, Kniss DA, et al.: Dysferlin is expressed in human placenta but does not associate with caveolin. Biol Reprod 2007; 77: 533-542.
31. Robinson JM, Ackerman WE 4th, Behrendt NJ, Vandre DD: While dysferlin and myoferlin are coexpressed in the human placenta, only dysferlin expression is responsive to trophoblast fusion in model systems. Biol Reprod 2009; 81: 33-39.
32. Miller J, Turan S, Baschat AA: Fetal growth restriction. Semin Perinatol 2008; 32: 274-280.
33. Barker DJ: Adult consequences of fetal growth restriction. Clin Obstet Gynecol 2006; 49: 270-283. (Pubitemid 44317915)
34. Chen B, Nelson DM, Sadovsky Y: N-myc down-regulated gene 1 modulates the response of term human trophoblasts to hypoxic injury. J Biol Chem 2006; 281: 2764-2772. (Pubitemid 43845740)
35. Cartwright JE, Keogh RJ, Tissot van Patot MC: Hypoxia and placental remodelling. Adv Exp Med Biol 2007; 618: 113-126.
36. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
37. Ambros V: The functions of animal microRNAs. Nature 2004; 431: 350-355.
38. Chang TC, Mendell JT: microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 2007; 8: 215-239.
39. Croce CM, Calin GA: miRNAs, cancer, and stem cell division. Cell 2005; 122: 6-7. (Pubitemid 40977933)
40. Donker RB, Mouillet JF, Nelson DM, Sadovsky Y: The expression of Argonaute2 and related microRNA biogenesis proteins in normal and hypoxic trophoblasts. Mol Hum Reprod 2007; 13: 273-279.
41. Mouillet JF, Chu T, Nelson DM, Mishima T, Sadovsky Y: MiR-205 silences MED1 in hypoxic primary human trophoblasts. FASEB J 2010; in press.
42. Yanaihara N, Caplen N, Bowman E, et al.: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-198. (Pubitemid 43357945)
43. Seike M, Goto A, Okano T, et al.: MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci USA 2009; 106: 12085-12090.
44. Carninci P, Kasukawa T, Katayama S, et al.: The transcriptional landscape of the mammalian genome. Science 2005; 309: 1559-1563.
45. Cheng J, Kapranov P, Drenkow J, et al.: Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 2005; 308: 1149-1154. (Pubitemid 40696429)
46. Bertone P, Stole V, Royce TE, et al.: Global identification of human transcribed sequences with genome tiling arrays. Science 2004; 306: 2242-2246. (Pubitemid 40024458)
47. Kapranov P, Willingham AT, Gingeras TR: Genomewide transcription and the implications for genomic organization. Nat Rev Genet 2007; 8: 413-423. (Pubitemid 46789245)
48. Willingham AT, Gingeras TR: TUF love for "junk" DNA. Cell 2006; 125: 1215-1220.
49. Wutz A: Xist function: bridging chromatin and stem cells. Trends Genet 2007; 23: 457-464. (Pubitemid 47259575)
50. Goodrich JA, Kugel JF: Non-coding-RNA regulators of RNA polymerase II transcription. Nat Rev Mol Cell Biol 2006; 7: 612-616. (Pubitemid 44325352)
51. Efroni S, Duttagupta R, Cheng J, et al.: Global transcription in pluripotent embryonic stem cells. Cell Stem Cell 2008; 2: 437-447. (Pubitemid 351598083)
52. Lindsley RC, Gill JG, Kyba M, Murphy TL, Murphy KM: Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm. Development 2006; 133: 3787-3796. (Pubitemid 44650957)
53. Prudhomme W, Daley GQ, Zandstra P, Lauffenburger DA: Multivariate proteomic analysis of murine embryonic stem cell self-renewal versus differentiation signaling. Proc Natl Acad Sci USA 2004; 101: 2900-2905. (Pubitemid 38327708)
54. Kikuchi K, Fukuda M, Ito T, et al.: Transcripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation. Nucleic Acids Res 2009; 37: 4987-5000.
55. Pibouin L, Villaudy J, Ferbus D, et al.: Cloning of the mRNA of overexpression in colon carcinoma-1: a sequence overexpressed in a subset of colon carcinomas. Cancer Genet Cytogenet 2002; 133: 55-60. (Pubitemid 34224876)